• No results found

Polymyxin B (PMB)

Development and validation method for simultaneous quantification of neomycin and polymyxin B by HPLC-ELSD and comparison with microbiological method

Development and validation method for simultaneous quantification of neomycin and polymyxin B by HPLC-ELSD and comparison with microbiological method

... using the reverse phase method then post-column derivatization using o-phthalaldehyde (Shaikh et al., 1991). However, the derivatization procedure is difficult because the process is complicated and causes problems for ...

6

Polymyxin B Alleviates Angiotensin II Induced Stress Fiber Formation and Cellular Hypertrophy

Polymyxin B Alleviates Angiotensin II Induced Stress Fiber Formation and Cellular Hypertrophy

... Polymyxin B is a cyclic polypeptide antibiotic that clinically used in the treatment of multidrug-resistant patho- gens and medical device to remove circulating endotoxin by ...of polymyxin B ...

9

Rational use of intravenous polymyxin B and colistin: A review

Rational use of intravenous polymyxin B and colistin: A review

... parenteral polymyxin B is limited and very much depended on individual ...dreaded polymyxin-resistant Klebsiella pneumoniae has been observed (National Surveillance of Antibiotic Resistance, ...

9

Polymyxin B hemoperfusion: a mechanistic perspective

Polymyxin B hemoperfusion: a mechanistic perspective

... whereby polymyxin B is immobilized to a polystyrene-derived fiber in a hemo- perfusion device that is used to remove circulating endo- toxin was developed in Japan in the early 1990s [20] (Figure ...

8

Effectiveness of polymyxin B immobilized fiber column in sepsis: a systematic review

Effectiveness of polymyxin B immobilized fiber column in sepsis: a systematic review

... The search strategy and data abstraction were defined by a prospective protocol. We searched PubMed, and the Cochrane Collaboration Database through April 2006, using the following search terms: 'hemoperfusion or ...

12

Imprinted contact lenses for sustained release of polymyxin B and related antimicrobial peptides

Imprinted contact lenses for sustained release of polymyxin B and related antimicrobial peptides

... 18 Polymyxin B, a lipopeptide antibiotic that can electrostatically interact with the negatively charged lipopolysaccharide (LPS), exhibits a rapid activity against multidrug-resistant Gram-negative ...

21

Irreproducible and Uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes

Irreproducible and Uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes

... to polymyxin resistance have been observed in other genera of bac- ...of polymyxin-resistant ...of polymyxin-resistant ...with polymyxin resistance for ...affecting polymyxin ...

6

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry

Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry

... Background: In 2010, the EUPHAS 2 collaborative group created a registry with the purpose of recording data from critically ill patients suffering from severe sepsis and septic shock treated with ...

9

Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates

Hetero- and adaptive resistance to polymyxin B in OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates

... to polymyxin B was shown in 55% of 22 tested isolates (present in 7 of 15 clones), all demonstrating high-level resistance to polymyxin B (MIC = 64 ...lowest polymyxin B ...

5

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

... of polymyxin combined with imi- penem, rifampicin or azithromycin we were unable to detect reliable in-vitro synergy between polymyxin B and any of these agents versus epidemic strains of ...

5

Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates

Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates

... Rapid polymyxin NP test. According to the rapid polymyxin NP test protocol, a rapid polymyxin NP solution containing ...of polymyxin B was added to a portion of the rapid ...

5

CHEMICAL STUDIES ON POLYMYXIN B

CHEMICAL STUDIES ON POLYMYXIN B

... A method for the recovery, purification and crystallization of polymyxin B is described in which the fermentation broth is clarified, adsorbed on cotton sodium succinate, eluted, precipi[r] ...

7

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B Resistant Carbapenemase Producing Klebsiella pneumoniae

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B Resistant Carbapenemase Producing Klebsiella pneumoniae

... area. Polymyxin B is one of the few antimicrobials that retain reliable activity against these ...However, polymyxin B MICs are elevated against ...with polymyxin B against 12 ...

5

Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study

Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study

... One of the strength of our study was elimination of all possible confounding factors that can contribute to renal failure. We excluded patients from the study if they received any nephrotoxic drug. We also excluded ...

8

Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review

Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review

... on PMB-iSH have been found so ...intravenous PMB for 4 days, according to the descrip- tion by Lahiry ...venous PMB. They maintained that the cumulative effect of PMB might be a possible ...

7

LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E

LABORATORY AND CLINICAL STUDIES OF POLYMYXIN B AND E

... Twenty patients with severe urinary tract infections were treated with polymyxin intramuscularly administered over periods of one to six days- in dosages of 2 to 5.6 mgm.. per kilogram o[r] ...

5

Antimicrobial nodule-specific cysteine-rich peptides disturb the integrity of bacterial outer and inner membranes and cause loss of membrane potential

Antimicrobial nodule-specific cysteine-rich peptides disturb the integrity of bacterial outer and inner membranes and cause loss of membrane potential

... of Polymyxin B (PMB), which alters bacte- rial outer membrane permeability and then disrupts the cytoplasmic membrane of gram-negative bacteria ...1a, b), however, addition of the NCR247 ...

5

PubMedCentral-PMC5256686.pdf

PubMedCentral-PMC5256686.pdf

... Polymyxin B (PMB) is a polypeptide polymyxin that has not undergone the rigour of modern drug development but is increasingly being utilised as a drug of last ...of polymyxin ...

10

Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen antibody complexes

Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen antibody complexes

... deposition have not been clarified. We find that the procoagulant activity of human leukocytes is markedly increased after incubation with immunoglobulin and immune complexes. This procoagulant activity is evident after ...

10

AMERICAN ACADEMY OF PEDIATRICS, INC. PROCEEDINGS AND REPORTS

AMERICAN ACADEMY OF PEDIATRICS, INC. PROCEEDINGS AND REPORTS

... Primarily bacteriocidal agents in current use are penicillin, streptomycin, polymyxin B, bacitracin, and neomycin.. Primarily bac-.[r] ...

12

Show all 10000 documents...

Related subjects